00092sek
0,0 %
Date:2025-04-03Time:11:02:45Latest report:Q4-2024List:SpotlightTicker:SPERM
Market Cap:25 msekEnterprise Value:24 msekNet Sales:- msekEarnings:-10,2 msekEmployees:0ISIN:SE0015346424

Ratios

10-year key figure history for Spermosens turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Spermosens with index and moving average MA50 and MA200.

Stockprice:0,0092
MA50:0,01
MA200:0,02
Price/MA200:-60,7 %
RSI (14):55,6
Price/MA50:7,6 %

Description

Spermosens is developing a technology for male fertility diagnostics for fertility treatment. Based on the patented technology, Spermosens will initially be able to offer the global market in IVF a unique and innovative male fertility diagnosis, JUNO-Checked, which will be able to determine whether the sperm can bind to the egg cell, which is a prerequisite for fertilization to take place.

Pharmaceuticals